Former Viatris and Pfizer President Joins Kapsule Board

Menassie Taddese , the Former President Emerging Market for Pfizer Upjohn, which later became Viatris through a merger with Mylan, has joined Kapsule as a board member.?

Kapsule’s new approach makes high-quality healthcare data from Low Resource Settings available to pharmaceutical companies to help with Market Access and Clinical Trials.

Kapsule aggregates data from hospitals, pharmacies, insurers, and healthcare technologies from multiple countries to give our customers insights into patients and healthcare facilities.?

While our technology was developed for an African context, our approach has the potential to transform healthcare in Low and Middle Income countries around the world by connecting these health systems to the global market.?

Nobody understands the potential of this more than Menassie!

Through the VC firm African Renaissance Ventures, Menassie, will help Kapsule to realize the potential of their innovation, not only in Africa but throughout the developing world.?

We are excited to have Menassie on board, and continuing to have a fruitful journey with African Renaissance Ventures.